The ongoing legal assault on Medicare negotiation continues as AstraZeneca has filed a notice to appeal a federal judge’s ruling against the company’s lawsuit to overturn the program.
Federal Court Rejects Big Pharma’s "Strongest Arguments" Challenging Constitutionality of Medicare Negotiation Program, Marking Another Win For Patients
Patients For Affordable Drugs Launches New Website Aimed At Defending Medicare Negotiation
Patients For Affordable Drugs Continues to Fight Against Big Pharma's Attempts to Undermine Medicare Drug Price Negotiation As Some Of The Largest Drug Companies Have Their Day In Court
Patients For Affordable Drugs Responds to Judge's Ruling Against AstraZeneca in The Pharmaceutical Corporation’s Lawsuit Against Medicare Drug Price Negotiation
Patients For Affordable Drugs Continues Fight Against Big Pharma's Attempts To Undermine Medicare Drug Price Negotiation In Landmark Case: AstraZeneca Pharmaceuticals LP et al. v. Becerra et al.
Moderna, BioNTech And Pfizer Took Interest Only After The Key Discovery Funded By U.S. Taxpayers Through NIH
Patients And All Americans Should Be Getting A Better Deal On Vaccines They Paid To Make Possible
Update To The Hidden Hand: Big Pharma’s Influence On “Patient Advocacy Groups” Shows Industry’s Control Of The Haystack Project, No Patient Left Behind, And The Community Oncology Alliance
Patients For Affordable Drugs is the only independent national patient organization focused exclusively on achieving policy changes to lower the price of prescription drugs.
